STOCK TITAN

THERIVA BIOLOGICS INC (TOVX) Net Income by Year

TOVX

THERIVA BIOLOGICS INC reported a net loss of $23.7M in fiscal year 2025. This represents an increase of 7.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters THERIVA BIOLOGICS INC has filed alongside them.

FY2025 annual
Net Income -$23.7M
YoY +7.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TOVX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$23.7M+7.5%-$25.7M-39.8%-$18.3M+6.8%-$19.7M-38.0%-$14.3M-42.1%-$10.0M+34.4%-$15.3M-14.5%-$13.4M+11.9%-$15.2M+44.3%-$27.3M+37.7%-$43.7M-121.1%-$19.8M-60.6%-$12.3M+27.8%-$17.1M-109.4%-$8.1M

TOVX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$3.2M+75.4%-$2.0M+52.7%N/A-$4.4M+43.6%-$13.1M-57.0%-$4.3M+16.3%N/A-$7.7M-133.9%-$8.3M-63.6%-$5.2M-15.3%N/A-$3.3M+26.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More THERIVA BIOLOGICS INC financials

Frequently Asked Questions

What was THERIVA BIOLOGICS INC's net income in fiscal year 2025?

THERIVA BIOLOGICS INC reported a net loss of $23.7M in fiscal year 2025.

How fast is THERIVA BIOLOGICS INC's net income growing?

THERIVA BIOLOGICS INC (TOVX) net income rose by 7.5% year over year, from -$25.7M to -$23.7M in fiscal year 2025.

How has THERIVA BIOLOGICS INC's net income changed over the years?

Across the 15 fiscal years this page covers, THERIVA BIOLOGICS INC (TOVX) net income went from -$8.1M in fiscal year 2011 to -$23.7M in fiscal year 2025.

THERIVA BIOLOGICS INC (TOVX) reported -$3.2M in net income in Q2 2026. This represents an increase of 75.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what THERIVA BIOLOGICS INC (TOVX) reported on that line in every period on record.